Cardio Diagnostics Holdings, Inc. (CDIO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CDIO
- Company Cardio Diagnostics Holdings, Inc.
- Price $2.24
- Changes Percentage 5.16
- Change 0.11
- Day Low $2.07
- Day High $2.69
- Year High $20.34
- Year Low $0.97
- Market Cap $4,090,354
- Price Avg 50 EMA (D) $2.4
- Price Avg 200 EMA (D) $3.85
- Exchange NASDAQ
- Volume 15,023,655
- Average Volume 431,306
- Open $2.37
- Previous Close $2.13
- EPS -11.91
- PE -0.19
- Earnings Announcement 2026-03-12 21:00:00
- Shares Outstanding $1,826,051
Company brief: CARDIO DIAGNOSTICS HOLDINGS, INC. (CDIO )
- Healthcare
- Biotechnology
- Dr. Meeshanthini V. Dogan Ph.D.
- https://cardiodiagnosticsinc.com
- US
- N/A
- 01-14-2022
- US14159C1036
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
CDIO Corporation News
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026
businesswire.com -- CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will host an investor conference call on Wednesday, February 18, 2026, at 3 p.m. Central Time....